BioSpace News Archive

Atrius Health, New England’s largest nonprofit independent medical group, and Firefly Health, a tech-enabled primary care and behavioral health provider, today announced a new affiliation to allow Firefly Health to contract through Atrius Health’s value-based collaboration with Blue Cross Blue Shield of Massachusetts servicing HMO and PPO patients, starting in February 2020.

Proteomics company CDI adds HuScan™ (PhIP-Seq patient biomarker discovery platform) and VirScan™ (PhIP-Seq antibody detection assays that includes every known human and viral protein).

Drawbridge Health today announced that it has completed the CE Mark process for the OneDraw™ A1C Test System – a novel, easy to use device that enables blood to be drawn comfortably and conveniently by a healthcare professional (HCP).

Geocent, LLC announced today that the company earned a Capability Maturity Model Integration (CMMI®) for Development Maturity Level 3 rating.

PRO-TECH Design & Manufacturing, a full-service FDA- and ISO-registered medical device contract manufacturing and packaging company, celebrates its 40-year anniversary in 2020.

A federal judge in Nashville, TN, has awarded $15.1 to a teen who sustained a severe brain injury at birth at the Fort Campbell Army hospital.

The Children’s Heart Foundation’s Ohio Region will host Hops for Hearts this Friday, Feb. 7, from 6-10 p.m. at Wolf’s Ridge Brewing in Columbus..

PTU Elite: CSPT® Prep Program Supports Growing Need for Highly-Trained, Sterile-Compounding-Certified Pharmacy Technicians and Promotes Commitment to Medication Safety [04-February-2020] DENVER , Feb. 4, 2020 /PRNewswire/ -- TRC® Healthcare (Therapeutic Research Center or TRC®), a leading provider of medication advisory and learning solutions and the author of Phar

The Delta Dental of Virginia Foundation is excited to announce that it has awarded nearly $400,000 to 50 organizations across the Commonwealth to fund research, educational outreach and other programs designed to improve the oral and overall health of Virginians.

Data continue to support potential of once-weekly VIP analogue for adults with pulmonary arterial hypertension